AIA - CA15.3 near me in Tinsukia

The AIA - CA15.3 is designed to detect potential cancer and monitor the treatment effectiveness. It measures the level of cancer antigen 15.3. It is most commonly used as a tumor marker to help evaluate the progression of breast cancer, particularly in individuals diagnosed with metastatic or advanced disease. Elevated CA15.3 levels can indicate the presence or growth of certain breast cancers, as some tumor cells release this antigen into the bloodstream. It is also found elevated in cancer of the ovary, colon, pancreas, and lungs. However, increased levels may also occur in non-cancerous conditions such as benign breast disorders, liver disease, or certain autoimmune conditions. For individuals undergoing breast cancer treatment, the CA15.3 test is frequently used to monitor response to therapy and to help detect potential recurrence. Tracking changes in CA15.3 over time provides meaningful insights into disease activity, supporting clinicians in making informed decisions about ongoing care. This test contributes valuable information for understanding overall health and treatment progress.

Disclaimer: Tumor markers (e.g., CA 15.3) are specialized tests that should not be used alone for cancer diagnosis due to potential false positives and negatives. They are most useful for monitoring high-risk patients, tracking disease progression, and assessing treatment response. They are unsuitable for vague symptoms or general screening because of their lack of specificity and potential elevation in benign conditions. Additionally, some procedures can temporarily raise tumor marker levels, so consult your doctor about the best timing for these tests.